Ingredient
Saussurea Lappa Root Extract
Saussurea Lappa Root Extract is flagged for pregnancy, breastfeeding, postpartum, trying to conceive, PCOS and general use. The concern behind the strongest flag is known teratogen and carcinogen concern.
- Costus Root Extract
- Aucklandia Lappa Root Extract
- Kuth Extract
Verdict by profile
Truva checks every ingredient against six profiles. Jump to any of them for the full assessment.
- Strongest verdict
- Not Recommended
- Its verdict for pregnancy, the profile this one is worst in
- Profiles flagged
- 6 of 6
- Counting avoid, high risk and medium risk
- Irritancy
- 2 of 5
- Higher means more likely to sting or redden
Saussurea Lappa Root Extract and pregnancy
Not Recommended
- Known teratogen
- Carcinogen concern
- Absorbed into the body
Saussurea lappa root extract contains aristolochic acids, which are classified by the International Agency for Research on Cancer as Group 1 carcinogens (known human carcinogens). These compounds are also nephrotoxic (toxic to kidneys) and mutagenic (can damage DNA). During pregnancy, aristolochic acids are particularly dangerous. They can cross the placental barrier and have been associated with fetal kidney damage and developmental abnormalities in animal studies. The FDA has specifically warned against the use of botanical ingredients containing aristolochic acids during pregnancy due to risks of birth defects and fetal toxicity. Even topical absorption, while lower than oral consumption, poses unacceptable risk given the severity of potential outcomes. The European Union banned costus root from cosmetics in 2005, and ACOG would categorize this as absolutely contraindicated during pregnancy. The substance has no safe level of exposure during pregnancy, and products containing it should be avoided entirely.
Saussurea Lappa Root Extract and breastfeeding
Not Recommended
- Passes into breast milk
- Infant exposure
- Carcinogen concern
Aristolochic acids are known carcinogens that can transfer into breast milk. The American Academy of Pediatrics and FDA have issued strong warnings against the use of any products containing aristolochic acids during lactation. Even with topical application, there is potential for systemic absorption and subsequent transfer to breast milk, exposing the infant to a known carcinogen. The infant's immature liver and kidneys make them particularly vulnerable to the nephrotoxic effects of aristolochic acids. Additionally, DNA damage from these compounds poses long-term cancer risk. There is absolutely no safe use scenario for this ingredient during breastfeeding. The EU ban and medical consensus are clear: avoid completely.
Saussurea Lappa Root Extract and postpartum
Not Recommended
- Carcinogen concern
Even for postpartum women who are not breastfeeding, Saussurea lappa root extract poses significant health risks due to its aristolochic acid content. These compounds are known human carcinogens and nephrotoxins regardless of reproductive status. The carcinogenic risk is not limited to pregnancy or breastfeeding—it applies to all individuals. The EU cosmetics ban reflects the unacceptable risk of topical exposure to aristolochic acids. Postpartum women should avoid this ingredient entirely, just as any person should avoid known carcinogens in personal care products.
Saussurea Lappa Root Extract and trying to conceive
Not Recommended
- Fertility effects
- Carcinogen concern
- Builds up in tissue
Aristolochic acids are mutagenic and can damage DNA, which raises concerns about egg quality and fertility. Additionally, these compounds accumulate in body tissues and can persist for months, meaning exposure while trying to conceive could affect early pregnancy. Reproductive endocrinologists and fertility specialists strongly advise against any exposure to aristolochic acids when planning pregnancy. The compounds' carcinogenic and mutagenic properties make them incompatible with preconception health optimization.
Saussurea Lappa Root Extract and PCOS
Not Recommended
- Carcinogen concern
The carcinogenic and nephrotoxic properties of aristolochic acids in Saussurea lappa root extract pose serious health risks regardless of PCOS status. This is not a condition-specific concern but a universal safety issue. Women with PCOS should avoid this ingredient entirely. While some may seek anti-inflammatory botanicals for PCOS-related skin issues, there are numerous safer alternatives that do not contain known carcinogens. The EU ban on this ingredient in cosmetics is comprehensive and not specific to any condition. Dermatologists treating PCOS patients would never recommend products containing aristolochic acids.
Saussurea Lappa Root Extract and general use
Not Recommended
- Carcinogen concern
- Common allergen
Saussurea lappa root extract contains aristolochic acids, which are classified by the International Agency for Research on Cancer (IARC) as Group 1 carcinogens—the same category as tobacco and asbestos. These compounds cause kidney damage and have been linked to urothelial cancer. The European Union banned costus root and its derivatives from cosmetics in 2005 specifically due to the presence of carcinogenic aristolochic acids. The FDA has issued multiple warnings about products containing these compounds, noting that no safe level of exposure has been established. Any cosmetic product containing this ingredient should be avoided by all consumers, regardless of age or health status. The risks far outweigh any potential cosmetic benefits, and numerous safer alternatives exist for anti-inflammatory or skin-soothing purposes.
Everything else flagged for the same profiles
Related ingredients
Ingredients suggested in place of Saussurea Lappa Root Extract, each one with its own page here.
Ingredients that raise the same concerns.
Where this came from
Truva summarises published guidance from bodies including ACOG, the FDA, the EU SCCS and the Cosmetic Ingredient Review. It has no access to your medical history and it is not a substitute for your doctor, dermatologist or midwife. These assessments have not been reviewed by a clinician, and nothing here is a diagnosis or a prescription. If you are pregnant, breastfeeding or being treated for PCOS, take the ingredient list to the person looking after you.
Assessment last pulled from the ingredient database on .
One ingredient is the easy case.
A label has thirty of them. Truva reads the whole list at once and answers for the profile you set: pregnancy, breastfeeding, postpartum, trying to conceive, PCOS, or general use.
Download on theApp Store